Skip to content

Study · Measured the body's own peptide · 1991

2 results

Differential expression of thymosin genes in human tumors and in the developing human kidney.

Hall AK

International journal of cancer1 Jul 1991Cited by 68 (Europe PMC)

PMID2071228 (opens in a new tab)DOI10.1002/ijc.2910480507 (opens in a new tab)PepBankPUB-02071228
Publisher pagePubMedAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Natural levels measured2

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In human tissues, thymosin beta‑4 mRNA was more abundant in malignant renal tumors than in normal tissues.

    In plain wordsHuman kidney tumors had more of the body's own thymosin beta‑4 messenger RNA than normal tissues.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    IncreaseThymosin beta 4 mRNA in malignant renal tumors
    Study

    n: not reported in source

    Comparator
    Normal tissues
    Outcome group
    Gene expression · Cancer

    Source sentences

    Summary
    Low levels of beta 4 and beta 10 mRNA species prevailed in normal tissues; in contrast, these gene transcripts were notably more abundant in malignant renal tumors and in the normal human embryonic kidney.
    1 context sentence
    Summary · context
    These observations prompted the present study which has used cDNA and synthetic oligonucleotide probes in combination with high-performance liquid chromatography (HPLC) to examine the differential expression of these 2 genes in normal and neoplastic human tissues and in the developing human kidney.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

  2. 02HumanEndogenous levelObservational studyOther

    In human tissues, thymosin beta‑4 mRNA was more abundant in the normal human embryonic kidney than in normal tissues.

    In plain wordsThe developing human kidney had more of the body's own thymosin beta‑4 messenger RNA than normal tissues.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    IncreaseThymosin beta 4 mRNA in embryonic kidney
    Study

    n: not reported in source

    Comparator
    Normal tissues
    Outcome group
    Gene expression · Kidney and urinary

    Source sentences

    Summary
    Low levels of beta 4 and beta 10 mRNA species prevailed in normal tissues; in contrast, these gene transcripts were notably more abundant in malignant renal tumors and in the normal human embryonic kidney.
    1 context sentence
    Summary · context
    These observations prompted the present study which has used cDNA and synthetic oligonucleotide probes in combination with high-performance liquid chromatography (HPLC) to examine the differential expression of these 2 genes in normal and neoplastic human tissues and in the developing human kidney.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.